JSF Financial LLC Grows Holdings in Cardinal Health, Inc. $CAH

JSF Financial LLC raised its holdings in Cardinal Health, Inc. (NYSE:CAH) by 4.4% during the second quarter, HoldingsChannel reports. The firm owned 9,448 shares of the company’s stock after buying an additional 397 shares during the period. JSF Financial LLC’s holdings in Cardinal Health were worth $1,587,000 as of its most recent filing with the SEC.

A number of other institutional investors also recently bought and sold shares of the business. JPMorgan Chase & Co. grew its holdings in shares of Cardinal Health by 40.0% during the first quarter. JPMorgan Chase & Co. now owns 4,175,992 shares of the company’s stock worth $575,327,000 after buying an additional 1,193,983 shares during the last quarter. Northern Trust Corp lifted its position in Cardinal Health by 3.5% during the 1st quarter. Northern Trust Corp now owns 3,143,003 shares of the company’s stock worth $433,012,000 after acquiring an additional 105,154 shares during the period. Wellington Management Group LLP raised its stake in shares of Cardinal Health by 1,666.7% during the first quarter. Wellington Management Group LLP now owns 2,384,192 shares of the company’s stock worth $328,470,000 after purchasing an additional 2,249,241 shares during the last quarter. Price T Rowe Associates Inc. MD raised its stake in shares of Cardinal Health by 3.3% during the first quarter. Price T Rowe Associates Inc. MD now owns 1,654,036 shares of the company’s stock worth $227,877,000 after purchasing an additional 52,714 shares during the last quarter. Finally, Dimensional Fund Advisors LP raised its stake in shares of Cardinal Health by 0.6% during the first quarter. Dimensional Fund Advisors LP now owns 1,246,788 shares of the company’s stock worth $171,749,000 after purchasing an additional 7,940 shares during the last quarter. 87.17% of the stock is currently owned by institutional investors and hedge funds.

Insider Buying and Selling at Cardinal Health

In other Cardinal Health news, CEO Stephen M. Mason sold 41,575 shares of the firm’s stock in a transaction dated Tuesday, August 19th. The shares were sold at an average price of $148.82, for a total transaction of $6,187,191.50. Following the completion of the transaction, the chief executive officer directly owned 26,085 shares in the company, valued at approximately $3,881,969.70. This trade represents a 61.45% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, insider Michelle D. Greene sold 13,500 shares of the firm’s stock in a transaction dated Tuesday, August 19th. The shares were sold at an average price of $148.82, for a total transaction of $2,009,070.00. Following the transaction, the insider owned 14,976 shares of the company’s stock, valued at $2,228,728.32. This trade represents a 47.41% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 271,676 shares of company stock worth $40,489,525. Insiders own 0.12% of the company’s stock.

Cardinal Health Stock Down 2.5%

Shares of NYSE CAH opened at $154.50 on Friday. Cardinal Health, Inc. has a 52 week low of $106.98 and a 52 week high of $168.44. The stock has a market capitalization of $36.71 billion, a price-to-earnings ratio of 23.95, a price-to-earnings-growth ratio of 1.31 and a beta of 0.71. The firm has a 50-day moving average price of $152.07 and a 200 day moving average price of $150.38.

Cardinal Health (NYSE:CAH) last issued its earnings results on Tuesday, August 12th. The company reported $2.08 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.03 by $0.05. The company had revenue of $60.16 billion during the quarter, compared to analysts’ expectations of $60.91 billion. Cardinal Health had a net margin of 0.70% and a negative return on equity of 74.45%. The firm’s quarterly revenue was up .5% compared to the same quarter last year. During the same period last year, the company posted $1.84 earnings per share. Cardinal Health has set its FY 2026 guidance at 9.300-9.500 EPS. Equities research analysts expect that Cardinal Health, Inc. will post 7.95 EPS for the current fiscal year.

Cardinal Health Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Wednesday, October 15th. Shareholders of record on Wednesday, October 1st will be given a dividend of $0.5107 per share. This represents a $2.04 dividend on an annualized basis and a yield of 1.3%. The ex-dividend date is Wednesday, October 1st. Cardinal Health’s payout ratio is presently 31.63%.

Analysts Set New Price Targets

Several equities analysts have issued reports on the stock. Argus set a $189.00 price objective on shares of Cardinal Health in a research note on Friday, August 22nd. UBS Group reaffirmed a “buy” rating on shares of Cardinal Health in a report on Tuesday, August 12th. Leerink Partners reduced their price objective on shares of Cardinal Health from $188.00 to $186.00 and set an “outperform” rating for the company in a research report on Tuesday, August 12th. Morgan Stanley restated an “overweight” rating on shares of Cardinal Health in a research report on Tuesday, August 12th. Finally, Weiss Ratings reissued a “buy (b)” rating on shares of Cardinal Health in a research note on Saturday, September 27th. Twelve research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company. According to data from MarketBeat, Cardinal Health has a consensus rating of “Moderate Buy” and a consensus target price of $165.93.

About Cardinal Health

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.